Harlow, United Kingdom

Stuart Ward

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 64(Granted Patents)


Location History:

  • Royston, GB (2013)
  • Harlow, GB (2014 - 2021)
  • Essex, GB (2018 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Journey of Stuart Ward: Pioneering Pharmaceuticals

Introduction: Stuart Ward, an esteemed inventor hailing from Harlow, GB, has made significant contributions to the field of pharmaceuticals. With an impressive 14 patents to his name, Ward is a trailblazer in developing compounds aimed at treating inflammatory diseases and disorders.

Latest Patents:

1. Pyridazine derivatives as RORc modulators: Ward's innovative compounds aim to modulate RORc, offering new possibilities for the treatment of inflammatory diseases like arthritis.

2. Oxadiazolones as transient receptor potential channel inhibitors: His inventions focus on inhibiting TRPA1, potentially benefiting individuals suffering from respiratory disorders and pain.

Career Highlights: Ward's exemplary work can be attributed to his tenure at Genentech, Inc., where he continues to push the boundaries of pharmaceutical research and development. His dedication to innovation has led to groundbreaking patents that have the potential to revolutionize treatment methodologies.

Collaborations: In his quest for innovation, Ward has collaborated closely with industry peers such as Benjamin Fauber and Monique Bodil van Niel. Together, they have fostered a culture of creativity and excellence, driving forward advancements in pharmaceutical science.

Conclusion: Stuart Ward's remarkable journey as an inventor underscores his commitment to improving healthcare outcomes through groundbreaking pharmaceutical inventions. His relentless pursuit of innovation serves as an inspiration to aspiring inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…